Anaemia, a common hematological disorder in HIV infection,
compromises the quality of life and treatment outcomes. At The AIDS Support Organisation
(TASO), Entebbe, the records for the 2016-2018 period show a 10% prevalence of anaemia
which is lower than that in literature where it is said to be up to 95%. This study
determined the prevalence, type, severity, and determinants of anaemia among people
living with HIV and AIDS who receive care from TASO Entebbe in Uganda. A questionnaire
was used to collect data from 624 TASO clients. A checklist identified the clients’
Antiretroviral Therapy (ART) combination and viral load. The selected clients’ Body
Mass Index (BMI) was calculated to assess their nutritional status. A Fully Automated
Humacount 60TS Three-Part Hematology Analyzer was used to measure hemoglobin and
to do a full blood count. A blood film from each sample was manually examined for
the type of anaemia. Data analysis was done with Stata MP 15. The prevalence of
anaemia was 44.4%, and the anaemia was mostly mild (54.15%) to moderate (40.80%).
Anaemia of inflammation was the commonest type (>58%). Gender, viral suppression,
nutritional status, nutritional education, marital and economic status were significantly
associated with the anaemia. Duration on ART had a protective effect, but this was
not statistically significant. The prevalence of anaemia
(44.4%) among the TASO-Entebbe Uganda clients was high, but the anaemia was mostly
mild to moderate (>94%) and of inflammation type (>58%). Management of anaemia
in HIV requires intentional screening since it compromises treatment outcomes.
 WHO. Haemoglobin
concentrations for the diagnosis of anaemia and assessment of severity. WHO/NMH/NHD/MNM/11.1.
 WHO. Worldwide
prevalence of anaemia 1993–2005 WHO Global Database on Anaemia. 2008. https://apps.who.int/iris/bitstream/handle/10665/43894/9789241596657_eng.pdf;jsessionid=D8A6BB532C215E958051A421AE7CE613?sequence=1.
NJ. The Global Burden of anaemia. 2013. https://www.sciencedirect.com/sdfe/pdf/download/eid/1-s2.0-S0889858815001896/first-page-pdf.
 WHO. Anaemia.
CM., & Suchdev, PS. anaemia epidemiology, pathophysiology, and etiology in low-
and middle-income countries. Annals of the New York Academy of Sciences,
1450(1), 15–31. 2019. https://doi.org/10.1111/nyas.14092.
B, Alem M, Melku M, et al., Prevalence and associated risk factors of anaemia among
HIV infected children attending Gondar university hospital, Northwest Ethiopia:
a cross sectional study. BMC hematology, 15, 12. 2015. https://doi.org/10.1186/s12878-015-0032-6.
Global HIV Statistics. 2019a. https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf.
Uganda AIDS Country Progress Report July 2017-June 2018. 2019b. https://www.unaids.org/sites/default/files/country/documents/UGA_2019_countryreport.pdf.
PS and Rhew DC. Prevalence and outcomes of anaemia in individuals with human immunodeficiency
virus: a Systematic Review of the Literature. 2004 Am J Med 116(Suppl7A):27S–43S.
CrossRef Medline Google Scholar.
A, Naman E, Gundersen SG. et al. Antiretroviral treatment reverses HIV-associated
anaemia in rural Tanzania. BMC Infect Dis 11, 190 (2011). https://doi.org/10.1186/1471-2334-11-190.
  Melese
H, Wassie MM, Woldie H, et al., anaemia among adult HIV patients in Ethiopia: a
hospital-based Cross-sectional study. HIV/AIDS (Auckland, N.Z.), 9, 25–30. 2017
 World Health Organization. Strategies to Prevent
anaemia, recommendation from an expert group consultation. 2015. www.who.int 20
Avenue Appia, 1211 Geneva 27, Switzerland.
 FAO. Nutritional
Status Assessment and Analysis Nutritional Status Indicators Learner Notes. 2007.
EM, Dallman P, Gurney JM, et al., World Health Organization. Preventing and Controlling
Iron Deficiency Anaemia Through Primary Health Care. A guide for Health Administrators
and Program Managers. 1989. https://www.who.int/nutrition/publications/micronutrients/anaemia_iron_deficiency/9241542497.pdf
(accessed on 25th September 2020).
 WHO. Haemoglobin
concentrations for the diagnosis of anaemia and assessment of severity. Vitamin
and Mineral Nutrition Information System. Geneva, World Health Organization. 2011b.
(WHO/NMH/NHD/MNM/11.1) http://www.who.int/vmnis/indicators/haemoglobin pdf, accessed
[19th September 2020].
Uganda at a glance; Facts and Figures. n.d. https://www.gou.go.ug/content/facts-figures.
 Lokpo SY,
Ofori-Attah P, Ameke LS, et al., “Viral Suppression and Its Associated Factors in
HIV Patients on Highly Active Antiretroviral Therapy (HAART): A Retrospective Study
in the Ho Municipality, Ghana”, AIDS Research and Treatment, vol. 2020, Article
ID 9247451, 7 pages, 2020. https://doi.org/10.1155/2020/9247451.
JH, Elliott JH, Bertagnolio S, et al., Viral suppression after 12 months of antiretroviral
therapy in low- and middle-income countries: a systematic review. Bulletin of
the World Health Organization, 91(5), 377–385E. 2013. https://doi.org/10.2471/BLT.12.112946.
F, Guwatudde D, Bwaninka JB, Makumbi FE, Lutalo T, Kagaayi J, Sewankambo NK, Kigozi
G, Serwadda DM, Kong X, Wawer MJ, Wabwire-Mangen F, & Gray RH. (2014). Marriage
and the risk of incident HIV infection in Rakai, Uganda. Journal of Acquired
Immune Deficiency Syndromes (1999), 65(1), 91–98. https://doi.org/10.1097/QAI.0b013e3182a7f08a.
DD, & Kline R. The association between remarriage and HIV infection in 13 sub-Saharan
African countries. Studies in family planning, 43 1, 1-10. 2012. https://doi.org/10.1111/j.1728-4465.2012.00297.x.
 UBOS. Statistical
Abstract. 2018. https://www.ubos.org/wpcontent/uploads/publications/05_2019STATISTICAL_ABSTRACT_2018.pdf.
 The World
Bank. Literacy rate, adult total (% of people ages 15 and above). From: https://data.worldbank.org/indicator/SE.ADT.LITR.ZS.
Accessed on the 26th of May 2020.
 WHO. Global
status report on alcohol and health. 2018a.
 MOH. Global
adult tobacco survey: country report 2013. 2013. https://www.health.go.ug/sites/default/files/GATS%20Uganda%20Country%20Report%20Final.pdf.
 UBOS. Demographic
and Health Survey. 2016. https://www.dhsprogram.com/pubs/pdf/FR333/FR333.pdf.
R, Saathoff E, Ezeamama AE. et al. Prevalence and correlates of cytopenias in HIV-infected
adults initiating highly active antiretroviral therapy in Uganda. BMC Infect Dis
14, 496. 2014. https://doi.org/10.1186/1471-2334-14-496.
JO, Shafer LA, Van der Paal L, et al., Aneamia in a rural Ugandan HIV cohort: prevalence
at enrolment, incidence, diagnosis, and associated factors. Medical Research Council
(MRC/UVRI) Uganda Research Unit on AIDS, Entebbe, Uganda. 2008.
 Denue BA,
Kida IM., Hammagabdo A, et al., Prevalence of anaemia and Immunological Markers
in HIV-Infected Patients on Highly Active Antiretroviral Therapy in North-eastern
Nigeria. Infectious diseases, 6, 25–33. 2013. https://doi.org/10.4137/IDRT.S10477.
WKBA, Quaye L, Amidu N, Addai-Mensah O. Prevalence of anaemia and immunological
markers among Ghanaian HAART-naïve HIV-patients and those on HAART. Afr Health Sci.
 Tamir Z,
Alemu J, & Tsegaye A. anaemia among HIV Infected Individuals Taking ART with
and without Zidovudine at Addis Ababa, Ethiopia. Ethiopian journal of health sciences,
28(1), 73–82. 2018. https://doi.org/10.4314/ejhs.v28i1.9.
PA, Levine AM, Dieterich D, et al., Clinical Impact and Evidence-Based Management
Strategies, Clinical Infectious Diseases, Volume 38, Issue 10, 15 May 2004, Pages
1454–1463, 2004. https://doi.org/10.1086/383031.
KB and Haye TB. 2019. Factors Associated with anaemia among People Living with HIV/AIDS
Taking ART in Ethiopia. 2019. https://www.hindawi.com/journals/ah/2019/9614205/.
JD and Mocroft A. anaemia and Survival in Human Immunodeficiency Virus. Clinical
Infectious Diseases 37(Suppl 4): S297–303 2003. https://academic.oup.com/cid/article/37/Supplement_4/S297/311072.
 Maskew M,
Brennan AT, Sanne I, et al., 2013. anaemia among HIV-Infected Patients Initiating
Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of
Degree of Immunosuppression and the Initiating ART Regimen. From: https://www.hindawi.com/journals/jtm/2013/162950/.
GG, Wondimu DH. Prevalence of anaemia before and after initiation of antiretroviral
therapy among HIV infected patients at Black Lion Specialized Hospital, Addis Ababa,
Ethiopia: a cross sectional study. BMC Hematol 18, 7. 2018. https://doi.org/10.1186/s12878-018-0099-y.
 Weiss G,
Ganz T and Goodnough LT. 2019. anaemia of inflammation: Iron Metabolism and Its
Disorders| January 3, 2019. From: https://ashpublications.org/blood/article/133/1/40/6617/ANAEMIA-of-inflammation.
 Ganz. T.
Molecular pathogenesis of anaemia of chronic disease. 2005. https://onlinelibrary.wiley.com/doi/full/10.1002/pbc.20656.
 Makubi A,
Okuma J, Spiegelman D, et al., Burden and Determinants of Severe anaemia among HIV-Infected
Adults: Results from a Large Urban HIV Program in Tanzania, East Africa. 2013. https://journals.sagepub.com/doi/10.1177/2325957413488195#bibr4-2325957413488195.
D, Walker AS, Ssali F, et al., DART Trial, & ARROW Trial. HIV-associated anaemia
after 96 weeks on therapy: determinants across age ranges in Uganda and Zimbabwe.
AIDS research and human retroviruses, 30(6), 523–530. 2014. https://doi.org/10.1089/aid.2013.0255.
 Sbarra DA.
(2015). Divorce and health: current trends and future directions. Psychosomatic
medicine, 77(3), 227–236. https://doi.org/10.1097/PSY.0000000000000168.
 NIH. 10
Things to Know About HIV Suppression. 2020. https://www.niaid.nih.gov/diseases-conditions/10-things-know-about-hiv-suppression.
 May MT, Gompels M, Delpech V, et al., UK Collaborative
HIV Cohort (UK CHIC) Study. Impact on the life expectancy of HIV-1 positive individuals
of CD4+ cell count and viral load response to antiretroviral therapy. AIDS (London,
England), 28(8), 1193–1202. 2014 https://doi.org/10.1097/QAD.0000000000000243.
 WHO. 2018b.
Viral suppression for HIV treatment success and prevention of sexual transmission
of HIV. From: https://www.who.int/hiv/mediacentre/news/viral-supression-hiv-transmission/en/.
 Bailey KV1
& Ferro-Luzzi A. Use of body mass index of adults in assessing individual and
community nutritional status. 1995. http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2486816&blobtype=pdf.
 WHO. 2020b.
Body mass index – BMI. From: https://www.euro.who.int/en/health-topics/disease-prevention/nutrition/a-healthy-lifestyle/body-mass-index-bmi.
 WHO. Malnutrition.
 Semba RD,
Shah N, Klein RS, et al.,, Human Immunodeficiency Virus Epidemiology Research Study
Group, Prevalence and Cumulative Incidence of and Risk Factors for anaemia in a
Multi-center Cohort Study of Human Immunodeficiency Virus–Infected and –Uninfected
Women, Clinical Infectious Diseases, Volume 34, Issue 2, 15 January 2002, Pages
MD and Darrell F. Anaemia in HIV-infected patients receiving highly active antiretroviral
therapy. Journal of acquired immune deficiency syndromes (1999), 29(1), 54–57. 2002.
 Yesuf T,
Muhie OA, Shibru H. Prevalence and predictors of anaemia among adult HIV infected
patients at the University of Gondar Hospital, Northwest Ethiopia. HIV AIDS (Auckl).
2019; 11:211-217 https://doi.org/10.2147/HIV.S209446.
 WHO. 2000.
Obesity: preventing and managing the global epidemic Report of a WHO Consultation
(WHO Technical Report Series 894). https://www.who.int/nutrition/publications/obesity/WHO_TRS_894/en/.